Trial no.:
|
PACTR202111889589868 |
Date of Approval:
|
10/11/2021 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
A Mobile Health Framework for Public-Private Mix in Tuberculosis Prevention and Care in Uganda |
Official scientific title |
A Mobile Health Framework for Public-Private Mix in Tuberculosis Prevention and Care in Uganda |
Brief summary describing the background
and objectives of the trial
|
Lack of mechanisms to track TB patients referred from private to public health facilities has led to increased delayed diagnosis and treatment initiation and lost follow-up and contact after referral. This has consequently resulted in increased disease severity, prolonged duration of infectivity and transmission at the household level, increased household expenditure in managing the disease, increases the risk of drug resistance (Law et al 2017), worsens the patients’ health conditions, and eventually leads to death in the Long run (Wood et al, 2010).
Despite the referrals, patients often delay going to the referral units due to the reluctance to transfer from private to public facilities. Most patients from private facilities end up getting lost to contact on a referral since it is usually difficult to know whether the referred patients reach the peripheral health units and initiated on TB treatment or not (Choun et al 2017 and O’hanlon et al 2016).
Mhealth-based tools like smartphone apps have been recommended by the World Health Organization for TB control efforts such as case identification and management, and patient support (Iribarren et al 2016, Musiimenta et al 2019). However, their feasibility, acceptability, and impact in enhancing Public Private Mix (PPM) for TB prevention and care remain unknown.
The following are the objectives for this trial.
1) To explore the barriers and motivators to private hospitals’ engagement in TB care.
2) To develop a mobile health framework for enhancing the tracking of TB patients referred from private to public hospitals and assess its initial acceptability and feasibility
3) To assess the preliminary impact of the developed framework on TB patients’ adherence to referrals for TB diagnosis and treatment in public hospitals |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
MOHE |
Disease(s) or condition(s) being studied |
Infections and Infestations |
Sub-Disease(s) or condition(s) being studied |
Tuberculosis |
Purpose of the trial |
Supportive care |
Anticipated trial start date |
15/11/2021 |
Actual trial start date |
|
Anticipated date of last follow up |
30/04/2022 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
80 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|